Accutar Biotech

/
/
AccutarBio
Biotech
Accutar Biotech is an innovative biotechnology company leveraging artificial intelligence for drug discovery. The company focuses on accelerating the development of targeted therapies in oncology through its AI-driven platform. With R&D centers in Shanghai, China, and the United States, Accutar combines cutting-edge computational science with biotechnology to advance precision medicine.
Project Introduction
AI-driven drug discovery requires multi-GAAP compliance and standardized global processes. This project enables automated procure-to-pay, online expense approvals, and full asset lifecycle management—establishing unified global data standards, integrating finance and operations, and enhancing procurement standardization and asset visibility.
Solutions
Multi-GAAP Support End-to-End Procure-to-Pay Management Online Expense Reimbursement Approval & Payment Fixed Asset Lifecycle Management Standardized Global Data Governance
Project Benefits
Global Financial Integration Standardized Procurement Processes Refined Expense Control Standardized Asset Management